Following its recent acquisition by Consort Medical, Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), has launched its new brand identity. This reflects the new alignment and consolidation of the full Consort Medical group.
The combination of Aesica and Bespak enables Consort Medical to provide customers with a single source for drug and device development, formulation, manufacturing and packaging. The group’s unrivalled global offering comprises advanced delivery technologies, formulation development and manufacturing solutions for drugs. The new logo and branding will be adopted across all Consort Medical businesses, creating a consistent identity for all group companies. The official launch to the market has been planned to coincide with CPhI 2015.
EP News Bureau – Mumbai